Article Text

other Versions

PDF
Testosterone: is it really time to treat his oomph?

Statistics from Altmetric.com

Over the last decade, developments in therapeutics increasingly have been directed at proxy markers and prevention rather than symptomatic treatment or cure, and this is particularly the case with late-onset hypogonadism in men (‘andropause’). Free seminars entitled “Restore the Man 2016”, sponsored by a pharmaceutical company, are currently being offered to doctors in England over the coming months to raise awareness; topics will include how to manage testosterone deficiency syndrome and how to evaluate risk of cardiovascular disease in men. A testosterone replacement gel has been advertised for some time now in journals with the strap line “Give him back his oomph”.

A carefully constructed argument has been developed that the male …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.